<DOC>
	<DOCNO>NCT01314963</DOCNO>
	<brief_summary>Lymphoscintigraphy accept commonly perform procedure use stag certain cancer , especially melanoma breast cancer . It involve inject small amount radioactivity skin order identify lymph node biopsied ( i.e. , `` sentinel node '' ) determine cancer spread . Our objective evaluate potential benefit new , camera-based technology allow actual image obtain intraoperatively identification sentinel node .</brief_summary>
	<brief_title>Efficacy Gamma Camera Used Intraoperatively ID Sentinel Lymph Nodes w/ Lymphoscintigraphy</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<criteria>3.1.1 Melanoma head neck lymphoscintigraphy sentinel lymph node biopsy recommend standard care 3.1.2 Prior therapy impact eligibility long sentinel lymph node biopsy indicate 3.1.4 Adults age 18 great . 3.1.5 No life expectancy restriction . 3.1.6 The patient must healthy enough surgery 3.1.8 Patients must able understand willing sign write informed consent document . 3.2.1 No therapy restriction . 3.2.2 No restriction use Investigational Agents . 3.2.3 No exclusion requirement due comorbid disease incurrent illness . 3.2.4 Patients exclude documented allergy colloid . 3.2.5 There know exclusion criterion relate concomitant medication substances potential affect activity pharmacokinetics study agent . 3.2.6 No agentspecific exclusion criterion . 3.2.7 Pregnant nursing patient exclude lymphoscintigraphy felt high risk . 3.2.8 Cancer survivor HIVpositive exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>